Used as a key intermediate in the synthesis of pharmaceutical agents, particularly in the development of central nervous system (CNS) active compounds. Its structural motif supports binding to neurotransmitter transporters, making it valuable in the creation of antidepressants and anxiolytics. The trans configuration enhances stereoselectivity, improving efficacy and reducing side effects in final drug products. Commonly employed in research settings for structure-activity relationship (SAR) studies of phenylcyclopropane derivatives. Also utilized in the preparation of selective monoamine reuptake inhibitors due to its favorable pharmacokinetic profile and metabolic stability.